The Healthcare Information and Management Systems Society has acquired Healthbox, looking to tap the business accelerator for its consulting and fund management capabilities.
Silicon Valley is home to an abundance of VC firms, all of them competing to get in on the next big deal. But VCs also exist (and succeed) outside of the Bay Area. While Washington, D.C. may not be an obvious location to establish a venture capital firm, Lavrock Ventures set its sights on the political capital. The firm announced today that it has closed its first fund at $25 million to invest in early-stage startups at the intersection of enterprise software, cybersecurity, and national security.
Personal Genome Diagnostics is adding to its IP portfolio to further develop new kinds of cancer tests.
A licensing deal announced Wednesday gives the Canton-based company exclusive rights to develop and commercialize products based on a key discovery at Memorial Sloan Kettering Cancer Center in New York. Financial terms were not disclosed.
Baltimore’s Sisu Global Health Inc. is launching its first medical device product and planning for growth in 2018.
Sisu, founded in 2014, specializes in creating health technologies to solve public health problems. The company is backed by $2.1 million in funding from various sources including local investors Camden Partners, the Abell Foundation and state-backed Maryland Technology Development Corp. It also won an investment from venture capitalist and AOL co-founder Steve Case, through his Rise of the Rest initiative.
When: Tuesday, March 27, 2018 from 4:00 PM to 7:30 PM EDT
Where: Montgomery College Pinkney Innovation Complex: Science & Technology 20200 Observation Drive Germantown, MD 20876
Join us for our first Women in Pharma event! This community is for those in the pharmaceutical/biotech industry and is a community of mentors, resources across all levels, and provide educational sessions that will be an enabler for career success and work-life balance. All are welcome.
The National Institute of Standards and Technology (NIST) is undertaking an ambitious plan to assess Federal technology transfer efforts to enable greater “Return on Investment” (ROI) from the Federal Government’s $140 Billion annual investment in research and development (R&D). NIST is uniquely positioned to implement this initiative through our government-wide leadership role within the Department of Commerce, including delegated (link is external) regulatory authority and responsibility for annual reporting to the President and Congress.
Studying such real-world evidence offers manufacturers a powerful tool to prove the value of their drugs – something Roche (ROG.S) aims to leverage, for example, with last month’s $2 billion purchase of Flatiron Health.
For decades, state and local economies have leaned heavily on their anchor institutions during times of economic uncertainty and transition. An analysis finds that total employment in “Eds and Meds” industries increased in every state from 2005 to 2015. This article breaks down the growth and geography of Eds and Meds employment at the state level, while next week’s issue of the Digest will explore this data by metropolitan area.
The i.Invest Competition is designed to help entrepreneurial-minded youth, ages 13 -19, further advance their business development and pitching skills and connect with mentors, judges and investors from across the country. The competition will:
- Showcase the entrepreneurial spirit of the nation’s brightest young leaders;
- Provide a venue for entrepreneurs to test their business plan and pitching capabilities;
- Offer opportunities for entrepreneurs to earn seed funding and connect with investors and potential customers;
- Position entrepreneurs to collaborate with mentors and coaches on the development of viable business models; and
- Provide opportunities for entrepreneurs to win cash and in-kind prizes.
Natalia Majewska spent the summer after her junior year at Northwestern University interning in a lab at MedImmune, the Gaithersburg, Maryland-based global biologics research and development arm of pharmaceutical giant AstraZeneca. There, she worked in a lab developing synthetic proteins.